CN101431996A - 蛋白质异戊二烯基转移酶的抑制剂 - Google Patents

蛋白质异戊二烯基转移酶的抑制剂 Download PDF

Info

Publication number
CN101431996A
CN101431996A CNA2007800144909A CN200780014490A CN101431996A CN 101431996 A CN101431996 A CN 101431996A CN A2007800144909 A CNA2007800144909 A CN A2007800144909A CN 200780014490 A CN200780014490 A CN 200780014490A CN 101431996 A CN101431996 A CN 101431996A
Authority
CN
China
Prior art keywords
compound
compounds
salt
cancer
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800144909A
Other languages
English (en)
Chinese (zh)
Inventor
玉野井冬彦
权五铉
渡边胜
汉娜·斐济
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Publication of CN101431996A publication Critical patent/CN101431996A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA2007800144909A 2006-03-22 2007-03-22 蛋白质异戊二烯基转移酶的抑制剂 Pending CN101431996A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78444306P 2006-03-22 2006-03-22
US60/784,443 2006-03-22

Publications (1)

Publication Number Publication Date
CN101431996A true CN101431996A (zh) 2009-05-13

Family

ID=38541651

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800144909A Pending CN101431996A (zh) 2006-03-22 2007-03-22 蛋白质异戊二烯基转移酶的抑制剂

Country Status (7)

Country Link
US (1) US8093274B2 (https=)
EP (1) EP2007383A4 (https=)
JP (1) JP2009530392A (https=)
CN (1) CN101431996A (https=)
AU (1) AU2007229457A1 (https=)
CA (1) CA2647038A1 (https=)
WO (1) WO2007111948A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574041A (zh) * 2020-12-25 2021-03-30 温州大学新材料与产业技术研究院 一种手性β羟基1,3-二羰基类化合物的合成方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
CN101495116A (zh) 2005-03-22 2009-07-29 哈佛大学校长及研究员协会 蛋白降解病症的治疗
AU2007345292B2 (en) 2006-02-14 2013-10-31 Dana-Farber Cancer Institute, Inc. Bifunctional histone deacetylase inhibitors
CA2647038A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
CA2654540C (en) * 2006-05-03 2017-01-17 President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
RU2515611C2 (ru) 2008-07-23 2014-05-20 Президент Энд Феллоуз Оф Гарвард Колледж Ингибиторы деацетилазы и их применение
WO2010014054A1 (en) 2008-07-28 2010-02-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
US9125821B2 (en) 2008-07-28 2015-09-08 The Regents Of The University Of California Nanodrug targeting protein geranylgeranylation
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
WO2012097371A2 (en) * 2011-01-14 2012-07-19 The Regents Of The University Of California Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
EP2963039A1 (en) * 2011-02-24 2016-01-06 The Regents of The University of California Small molecules for endothelial cell activation
HUE045348T2 (hu) 2011-05-08 2019-12-30 Legochem Biosciences Inc Fehérje-hatóanyag konjugátumok és eljárás elõállításukra
EP2836482B1 (en) * 2012-04-10 2019-12-25 The Regents of The University of California Compositions and methods for treating cancer
EP3698797A1 (en) 2017-10-16 2020-08-26 Tsinghua University Mevalonic acid pathway inhibitor and pharmaceutical composition thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
AU2003259717A1 (en) 2002-08-07 2004-02-25 Bristol-Myers Squibb Company Modulators of rabggt and methods of use thereof
MXPA05013770A (es) 2003-06-19 2006-03-08 Pfizer Prod Inc Antagonista de neuroquinina 1.
CA2647038A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574041A (zh) * 2020-12-25 2021-03-30 温州大学新材料与产业技术研究院 一种手性β羟基1,3-二羰基类化合物的合成方法

Also Published As

Publication number Publication date
AU2007229457A1 (en) 2007-10-04
EP2007383A4 (en) 2010-09-15
JP2009530392A (ja) 2009-08-27
EP2007383A2 (en) 2008-12-31
US20100063114A1 (en) 2010-03-11
WO2007111948A2 (en) 2007-10-04
US8093274B2 (en) 2012-01-10
CA2647038A1 (en) 2007-10-04
WO2007111948A3 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
US8093274B2 (en) Inhibitors of protein prenyltransferases
US8815935B2 (en) Inhibitors of protein prenyltransferases
Hafez et al. Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
EP3529240B1 (en) Pharmaceutical compounds
EP2486005A1 (en) Pyrrolidine gpr40 modulators
PH12014501162B1 (en) Aryl dihydropyridinone and piperidinone as mgat2 inhibitors
US8404738B2 (en) 4-amino-N-hydroxy-benzamides for the treatment of cancer
US9365558B2 (en) Dihydropyridinone MGAT2 inhibitors
Mariaule et al. 3-Oxo-hexahydro-1 H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors
Chamakuri et al. Synthesis of enantiomerically pure 6-substituted-piperazine-2-acetic acid esters as intermediates for library production
Reddy et al. HDAC and NF-κB mediated cytotoxicity induced by novel N-Chloro β-lactams and benzisoxazole derivatives
ES2406085T3 (es) Derivados de fenil-metanona sustituida y su empleo como inhibidores de receptores de GlyT1 y GlyT2
Oliveira et al. Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors
EP2280940A1 (en) Novel n-(2-amino-phenyl)-acrylamides
EP2334658A2 (en) Ortho-aminoanilides for the treatment of cancer
Ayan et al. Asymmetric synthesis and molecular docking study of enantiomerically pure pyrrolidine derivatives with potential antithrombin activity
MX2007011072A (es) Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen.
Liu Novel concepts and methodologies in pseudo natural product chemistry
Cao et al. Identification of Novel β‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy
Pedrola Teixell Improved Preparative Chemical Methodologies to Address Challenging Targets: Synthetic, Semi-synthetic and Multicomponent Approaches
Akella Development of New Drugs for the Treatment of Oral Cancers
Johnston et al. Transcriptomic Signature and PROTAC Strategy Revealed Histone Lysine Demethylase as a Target of Anticancer Activity of Deferiprone
Ceusters Eight-membered cyclic amines as novel scaffolds for drug discovery
Osman SYNTHETIC AND BIOLOGICAL STUDIES ON ANALOGUES OF FR901464 AND TMC-205
Kim et al. Synthesis and biological evaluation of α-sulfonamido-N-adamantanecarboxamide derivatives as 11β-HSD1 inhibitors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090513